Literature DB >> 21398535

Non-identity-mediated CRISPR-bacteriophage interaction mediated via the Csy and Cas3 proteins.

Kyle C Cady1, George A O'Toole.   

Abstract

Studies of the Escherichia, Neisseria, Thermotoga, and Mycobacteria clustered regularly interspaced short palindromic repeat (CRISPR) subtypes have resulted in a model whereby CRISPRs function as a defense system against bacteriophage infection and conjugative plasmid transfer. In contrast, we previously showed that the Yersinia-subtype CRISPR region of Pseudomonas aeruginosa strain UCBPP-PA14 plays no detectable role in viral immunity but instead is required for bacteriophage DMS3-dependent inhibition of biofilm formation by P. aeruginosa. The goal of this study is to define the components of the Yersinia-subtype CRISPR region required to mediate this bacteriophage-host interaction. We show that the Yersinia-subtype-specific CRISPR-associated (Cas) proteins Csy4 and Csy2 are essential for small CRISPR RNA (crRNA) production in vivo, while the Csy1 and Csy3 proteins are not absolutely required for production of these small RNAs. Further, we present evidence that the core Cas protein Cas3 functions downstream of small crRNA production and that this protein requires functional HD (predicted phosphohydrolase) and DEXD/H (predicted helicase) domains to suppress biofilm formation in DMS3 lysogens. We also determined that only spacer 1, which is not identical to any region of the DMS3 genome, mediates the CRISPR-dependent loss of biofilm formation. Our evidence suggests that gene 42 of phage DMS3 (DMS3-42) is targeted by CRISPR2 spacer 1 and that this targeting tolerates multiple point mutations between the spacer and DMS3-42 target sequence. This work demonstrates how the interaction between P. aeruginosa strain UCBPP-PA14 and bacteriophage DMS3 can be used to further our understanding of the diverse roles of CRISPR system function in bacteria.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21398535      PMCID: PMC3133329          DOI: 10.1128/JB.01411-10

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  28 in total

Review 1.  CRISPR-based adaptive and heritable immunity in prokaryotes.

Authors:  John van der Oost; Matthijs M Jore; Edze R Westra; Magnus Lundgren; Stan J J Brouns
Journal:  Trends Biochem Sci       Date:  2009-07-29       Impact factor: 13.807

2.  Cyclic-di-GMP-mediated repression of swarming motility by Pseudomonas aeruginosa: the pilY1 gene and its impact on surface-associated behaviors.

Authors:  S L Kuchma; A E Ballok; J H Merritt; J H Hammond; W Lu; J D Rabinowitz; George A O'Toole
Journal:  J Bacteriol       Date:  2010-03-16       Impact factor: 3.490

3.  A 10-min method for preparation of highly electrocompetent Pseudomonas aeruginosa cells: application for DNA fragment transfer between chromosomes and plasmid transformation.

Authors:  Kyoung-Hee Choi; Ayush Kumar; Herbert P Schweizer
Journal:  J Microbiol Methods       Date:  2005-06-28       Impact factor: 2.363

4.  Diversity of CRISPR loci in Escherichia coli.

Authors:  C Díez-Villaseñor; C Almendros; J García-Martínez; F J M Mojica
Journal:  Microbiology       Date:  2010-02-04       Impact factor: 2.777

5.  Analysis of CRISPR in Streptococcus mutans suggests frequent occurrence of acquired immunity against infection by M102-like bacteriophages.

Authors:  Jan R van der Ploeg
Journal:  Microbiology       Date:  2009-04-21       Impact factor: 2.777

6.  CRISPR interference limits horizontal gene transfer in staphylococci by targeting DNA.

Authors:  Luciano A Marraffini; Erik J Sontheimer
Journal:  Science       Date:  2008-12-19       Impact factor: 47.728

7.  Phage response to CRISPR-encoded resistance in Streptococcus thermophilus.

Authors:  Hélène Deveau; Rodolphe Barrangou; Josiane E Garneau; Jessica Labonté; Christophe Fremaux; Patrick Boyaval; Dennis A Romero; Philippe Horvath; Sylvain Moineau
Journal:  J Bacteriol       Date:  2007-12-07       Impact factor: 3.490

8.  Structural basis for DNase activity of a conserved protein implicated in CRISPR-mediated genome defense.

Authors:  Blake Wiedenheft; Kaihong Zhou; Martin Jinek; Scott M Coyle; Wendy Ma; Jennifer A Doudna
Journal:  Structure       Date:  2009-06-10       Impact factor: 5.006

9.  Sequence- and structure-specific RNA processing by a CRISPR endonuclease.

Authors:  Rachel E Haurwitz; Martin Jinek; Blake Wiedenheft; Kaihong Zhou; Jennifer A Doudna
Journal:  Science       Date:  2010-09-10       Impact factor: 47.728

10.  Prevalence, conservation and functional analysis of Yersinia and Escherichia CRISPR regions in clinical Pseudomonas aeruginosa isolates.

Authors:  K C Cady; A S White; J H Hammond; M D Abendroth; R S G Karthikeyan; P Lalitha; M E Zegans; G A O'Toole
Journal:  Microbiology (Reading)       Date:  2010-11-16       Impact factor: 2.777

View more
  75 in total

1.  Characterization of the CRISPR/Cas subtype I-A system of the hyperthermophilic crenarchaeon Thermoproteus tenax.

Authors:  André Plagens; Britta Tjaden; Anna Hagemann; Lennart Randau; Reinhard Hensel
Journal:  J Bacteriol       Date:  2012-03-09       Impact factor: 3.490

2.  Mechanism of substrate selection by a highly specific CRISPR endoribonuclease.

Authors:  Samuel H Sternberg; Rachel E Haurwitz; Jennifer A Doudna
Journal:  RNA       Date:  2012-02-16       Impact factor: 4.942

Review 3.  RNA-guided genetic silencing systems in bacteria and archaea.

Authors:  Blake Wiedenheft; Samuel H Sternberg; Jennifer A Doudna
Journal:  Nature       Date:  2012-02-15       Impact factor: 49.962

4.  Structure and activity of the Cas3 HD nuclease MJ0384, an effector enzyme of the CRISPR interference.

Authors:  Natalia Beloglazova; Pierre Petit; Robert Flick; Greg Brown; Alexei Savchenko; Alexander F Yakunin
Journal:  EMBO J       Date:  2011-10-18       Impact factor: 11.598

5.  A CRISPR-Cas system enhances envelope integrity mediating antibiotic resistance and inflammasome evasion.

Authors:  Timothy R Sampson; Brooke A Napier; Max R Schroeder; Rogier Louwen; Jinshi Zhao; Chui-Yoke Chin; Hannah K Ratner; Anna C Llewellyn; Crystal L Jones; Hamed Laroui; Didier Merlin; Pei Zhou; Hubert P Endtz; David S Weiss
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-14       Impact factor: 11.205

6.  DMS3-42: the secret to CRISPR-dependent biofilm inhibition in Pseudomonas aeruginosa.

Authors:  Kelli L Palmer; Marvin Whiteley
Journal:  J Bacteriol       Date:  2011-05-06       Impact factor: 3.490

7.  Structural and biochemical analysis of nuclease domain of clustered regularly interspaced short palindromic repeat (CRISPR)-associated protein 3 (Cas3).

Authors:  Sabin Mulepati; Scott Bailey
Journal:  J Biol Chem       Date:  2011-07-20       Impact factor: 5.157

Review 8.  Impact of CRISPR immunity on the emergence and virulence of bacterial pathogens.

Authors:  Asma Hatoum-Aslan; Luciano A Marraffini
Journal:  Curr Opin Microbiol       Date:  2013-12-29       Impact factor: 7.934

9.  Requirements for Pseudomonas aeruginosa Type I-F CRISPR-Cas Adaptation Determined Using a Biofilm Enrichment Assay.

Authors:  Gary E Heussler; Jon L Miller; Courtney E Price; Alan J Collins; George A O'Toole
Journal:  J Bacteriol       Date:  2016-10-21       Impact factor: 3.490

10.  Antibacterial efficacy of temperate phage-mediated inhibition of bacterial group motilities.

Authors:  In-Young Chung; Nuri Sim; You-Hee Cho
Journal:  Antimicrob Agents Chemother       Date:  2012-08-20       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.